Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 30 Jul 2026 for Aytu Biopharma, INC.
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
John Donofrio Jr.: trading record in brief
All filings by John Donofrio Jr. on record concern Aytu Biopharma, Inc. We count 9 filings; the first trade dates from 12 July 2016 and the latest from 28 July 2026.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 30 July 2026, reports a share grant in Aytu Biopharma, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to John Donofrio Jr.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
10,000 shares0Common StockSEC:0001437749-26-025075:0
10,000 shares0Common StockSEC:0001437749-25-030632:0
1,500 shares0Common SharesSEC:0000912282-24-000762:0
1,500 shares0Common SharesSEC:0000912282-23-000301:0
187,804 shares0Common StockSEC:0001567619-22-022004:0
5 of 5 declarations
